The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 NuVasive Inc.  (NUVA) Trade Now »     Rate NUVA  -  Discuss NUVA  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Medical Equipment & Supplies
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
77.5%
Top:
0.0%
Rate NUVA:



NUVA Analysis & Videos »


NUVA: Bull or Bear?

NuVasive, Inc. (NASDAQ:NUVA)-Top 10 Best-Rated Medical Equipment Stocks: STJ, COV, MDT, NUVA, SIRO, MR, EW, TMO, THOR, ZMH (Jun 01, 2010) Graphic_rating_buy NUVA
Foto
62%
 -42.32%
in 1114 days
http://suprastock.blogspot.com/2010/06/top-10-best-rated-medi... NuVasive, Inc. (NASDAQ:NUVA) is the 4th best-rated stock in this segment of the market. It is rated positively by 15 brokerage analysts. It is covered by 15 brokerage analysts
By  Marian Filo   (-24.55%  risk: aggressive)  06/01/10 9 comments


Nuvasive (NUVA): Growth in adult stem cells Graphic_rating_buy NUVA
-27.45%
in 1538 days

Filed under: Newsletters, Stocks to Buy

"In all the excitement over the new future for embryonic stem cell, it seems investors have forgotten about adult stem cell products," notes growth stock specialist Dave Dyer.

In his Dave Dyer's Newsletter, he explains, "In fact, there are adult stem cell products either already on the market or in late clinical trials. We view this as an excellent opportunity." Here, he looks at NuVasive (NASDAQ: NUVA).

<>"Stem cells can grow into any type of organ or tissue and the promise is that damaged organs may be repaired or even replaced with spare parts grown fro...
By  Steven Halpern   (+19.69%  risk: moderate)  04/03/09 1 comment


NUVA $5 TO $10 Target Price...Extremely Overvalued By Valuation...Why? Graphic_rating_sell NUVA
69%
 +51.95%
in 1717 days

NUVA is overvalued, looking only at valuation relative to its Industry.

* NUVA has a Projected P/E of 105.73 (huge)
* NUVA's Industry (Medical Instruments & Supplies) has an average Projected P/E of 22.32
* Implies a Projected Stock Price of $10.04

* NUVA has a projected earnings growth rate of 5.10%
* NUVA has a PEG of 20.73 (huge)
* NUVA's Industry (Medical Instruments & Supplies) has an average Projected PEG of 2.23
* Implies a Projected Stock Price of $5.12

Source of the analysis and calculations:

<> <> <>http://www.freestockvalueranker.com/...
By  energycurve   (+8.89%  risk: conservative)  10/05/08 6 comments


Get free stock alert for NUVA:
Your Email Address:


Bookkeeping: Initiating NuVasive (NUVA) Position Graphic_rating_buy NUVA
Tradermark
34%
 -53.68%
in 1750 days
NuVasive (NUVA) is a medical equipment stock I've been following for years; it's had long period of lulls followed by huge moves. We highlighted this stock in late July [Jul 25: NuVasive - At What Price Growth? It Seems "Any"] when it traded at a similar price to today. I wrote

I am reviewing an old watch list with a handful of "medical device" names I followed around the time I found Intuitive Surgical (ISRG) back in the middle part of the decade. NuVasive (NUVA)<> was a name that had one big pop at the time, and then traded sideways for a long time (between $15 - low $20s) for a long tim...
By  Trader Mark   (-2.37%  risk: moderate)  09/02/08 1 comment


Bullish on NUVA ... Graphic_rating_buy NUVA
Puppy_250x251
16%
 -11.98%
in 684 days
(closed on 10/28/09)
<> "NuVasive [NUVA]. It isn't an inexpensive stock, but it's a very early-stage stock with revenue growth around 60% being driven by new products. They have a product used in minimally invasive spine fusion surgery and they have a number of products under development that are potentially very interesting. One is an artificial disk product. There is nice potential upside if it works out. In the meantime, they have a very solid spinal-fusion business, which is driving all of the current estimates and growth rate."

http://online.barrons.com/article/SB119525667524396310.html?m... ...
By  J Alex   (-6.85%  risk: aggressive)  12/13/07 2 comments


3Q07 Earnings & Color on Growth Graphic_rating_buy NUVA
N/A
 -49.06%
in 2058 days

NUVA's 3Q results continue to demonstrate the revenue growth potential of the Company's product portfolio. Additionally, Management added color on 2008 sales growth potential of +35% y-o-y. While excellent news, I am inclined to agree with Lehman Brothers view that this number could prove conservative given the continued focus on expanding the sales force and the expected return from this investment to the revenue line. With this kind of growth story, a valuation premium to other medical device stocks is justified and should continue to support the valuation.

<> Given how far the stock ...
By  Allan S   (+7.50%  risk: aggressive)  10/30/07 10 comments





People Bullish on NUVA

Foto
Marian Filo
Principal
62%
over 3 years ago

Aaron Nice
Sr. Analyst
33%
over 3 years ago

Steven Halpern
Tracked Blogger
56%
over 4 years ago

Tradermark
Trader Mark
Analyst
34%
over 4 years ago

JIMMY T
Associate
17%
over 5 years ago


People Bearish on NUVA

energycurve
Associate
69%
over 4 years ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +32.13% 538
2 Gerald Greene 18.14 +6.82% 289
3 stockmarketfunding.com 17.66 +22.47% 85
4 akiralegrand 13.47 +13.86% 71
5 anup2104 12.13 +175.56% 106


POPULAR STOCKS
Symbol Company Name Sentiment
KO The CocaCola Company
CSCO Cisco Systems Inc
CHK Chesapeake Energy Corp
IBM International Business Machines Corp
GOOG Google Inc
POT Potash Corp. of Saskatchewan Inc.

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on NUVA


Discussion Wall + Add  
andrea   (-60.20%  risk: aggressive)
What do you think about NUVA and GSOL? - Good position for continued buying?
+   38 replies


More Resources

Graphic_arrow1 About NuVasive Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch